Literature DB >> 24756204

Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia.

Kevin F Bieniek1, Marka van Blitterswijk2, Matthew C Baker2, Leonard Petrucelli2, Rosa Rademakers2, Dennis W Dickson2.   

Abstract

IMPORTANCE: Expanded hexanucleotide repeats in C9ORF72 are a common genetic cause of frontotemporal dementia and amyotrophic lateral sclerosis. Repeat expansions have also been detected infrequently in other disorders, including Alzheimer disease, dementia with Lewy bodies, and parkinsonian disorders. OBSERVATIONS: A consecutive series of 31 cases from the brain bank for neurodegenerative disorders at Mayo Clinic was screened to assess the incidence of the expanded C9ORF72 repeat in cases of depressive pseudodementia. The presence of the hexanucleotide repeat was established using immunohistochemistry with a highly disease-specific antibody (C9RANT), and was further validated in carriers using repeat-primed polymerase chain reaction and Southern blotting. Two individuals harbored the C9ORF72 repeat expansion. Both patients were men with refractory depression. One patient experienced drug-induced parkinsonism and sudden-onset dementia, while the other patient had a more insidious disease course suspected to be Alzheimer disease. CONCLUSIONS AND RELEVANCE: This report increases the range of clinicopathologic presentations of C9ORF72 expanded hexanucleotide repeat to include psychiatric disorders such as depressive pseudodementia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756204      PMCID: PMC4197801          DOI: 10.1001/jamaneurol.2013.6368

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  20 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

2.  Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS.

Authors:  Peter E A Ash; Kevin F Bieniek; Tania F Gendron; Thomas Caulfield; Wen-Lang Lin; Mariely Dejesus-Hernandez; Marka M van Blitterswijk; Karen Jansen-West; Joseph W Paul; Rosa Rademakers; Kevin B Boylan; Dennis W Dickson; Leonard Petrucelli
Journal:  Neuron       Date:  2013-02-12       Impact factor: 17.173

3.  C9orf72 repeat expansions are a rare genetic cause of parkinsonism.

Authors:  Suzanne Lesage; Isabelle Le Ber; Christel Condroyer; Emmanuel Broussolle; Audrey Gabelle; Stéphane Thobois; Florence Pasquier; Karl Mondon; Patrick A Dion; Daniel Rochefort; Guy A Rouleau; Alexandra Dürr; Alexis Brice
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

4.  Long-term outcome of depressive pseudodementia in the elderly.

Authors:  J Andrés Sáez-Fonseca; Lean Lee; Zuzana Walker
Journal:  J Affect Disord       Date:  2006-12-20       Impact factor: 4.839

5.  Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.

Authors:  S G Lindquist; M Duno; M Batbayli; A Puschmann; H Braendgaard; S Mardosiene; K Svenstrup; L H Pinborg; K Vestergaard; L E Hjermind; J Stokholm; B B Andersen; P Johannsen; J E Nielsen
Journal:  Clin Genet       Date:  2012-07-04       Impact factor: 4.438

6.  TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies.

Authors:  Stacy J Arnold; Brittany N Dugger; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2013-04-20       Impact factor: 17.088

7.  The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.

Authors:  Kohji Mori; Shih-Ming Weng; Thomas Arzberger; Stephanie May; Kristin Rentzsch; Elisabeth Kremmer; Bettina Schmid; Hans A Kretzschmar; Marc Cruts; Christine Van Broeckhoven; Christian Haass; Dieter Edbauer
Journal:  Science       Date:  2013-02-07       Impact factor: 47.728

8.  Pseudodementia twelve years on.

Authors:  P S Sachdev; J S Smith; H Angus-Lepan; P Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-03       Impact factor: 10.154

9.  Repeat expansion in C9ORF72 in Alzheimer's disease.

Authors:  Elisa Majounie; Yevgeniya Abramzon; Alan E Renton; Rodney Perry; Susan S Bassett; Olga Pletnikova; Juan C Troncoso; John Hardy; Andrew B Singleton; Bryan J Traynor
Journal:  N Engl J Med       Date:  2012-01-04       Impact factor: 91.245

Review 10.  Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease.

Authors:  Leonel T Takada; Sharon J Sha
Journal:  Alzheimers Res Ther       Date:  2012-10-03       Impact factor: 6.982

View more
  16 in total

Review 1.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

Review 2.  [Genetics of dementia].

Authors:  J Diehl-Schmid; K Oexle
Journal:  Nervenarzt       Date:  2015-07       Impact factor: 1.214

Review 3.  Emerging role of RNA•DNA hybrids in C9orf72-linked neurodegeneration.

Authors:  Jiou Wang; Aaron R Haeusler; Eric A J Simko
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  G4-associated human diseases.

Authors:  Nancy Maizels
Journal:  EMBO Rep       Date:  2015-07-06       Impact factor: 8.807

Review 5.  Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Authors:  Nancy J Butcher; Erik Boot; Anthony E Lang; Danielle Andrade; Jacob Vorstman; Donna McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-05-19       Impact factor: 2.802

6.  Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72.

Authors:  Marka van Blitterswijk; Tania F Gendron; Matthew C Baker; Mariely DeJesus-Hernandez; NiCole A Finch; Patricia H Brown; Lillian M Daughrity; Melissa E Murray; Michael G Heckman; Jie Jiang; Clotilde Lagier-Tourenne; Dieter Edbauer; Don W Cleveland; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; Leonard Petrucelli; Bradley F Boeve; Neill R Graff-Radford; Kevin B Boylan; Dennis W Dickson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2015-10-05       Impact factor: 17.088

7.  Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.

Authors:  David J Irwin; Nigel J Cairns; Murray Grossman; Corey T McMillan; Edward B Lee; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-12-31       Impact factor: 17.088

Review 8.  C9orf72-Related Neurodegenerative Diseases: From Clinical Diagnosis to Therapeutic Strategies.

Authors:  Stefania Zampatti; Cristina Peconi; Rosa Campopiano; Stefano Gambardella; Carlo Caltagirone; Emiliano Giardina
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

9.  Hexanucleotide Repeat Expansion in C9ORF72 Is Not Detected in the Treatment-Resistant Schizophrenia Patients of Chinese Han.

Authors:  Xijia Xu; Shiping Xie; Xiaomeng Shi; Jie Lv; Xiaowei Tang; Xiaolan Wang; Shuiping Lu; Mingzhong Wang; Xiaobing Zhang; Jing Sun; Hui Yao
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

Review 10.  Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.

Authors:  Alberto Benussi; Alessandro Padovani; Barbara Borroni
Journal:  Front Aging Neurosci       Date:  2015-09-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.